L3VLUP

GRDN in the 13F filings

Guardian Pharmacy SVCS Inc · CUSIP 40145W101

New listing in Q3 2024· first held by a tracked manager this quarter, so its new positions are allocations rather than a turn towards it

Quarter end
30 Sep 2024
the date the book describes
Filed
14 Nov 2024
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 0 listed it in both
Shares listed
568,131
combined, among listed positions
Reported value
$9.5m
combined, at the quarter end

Among the 94 comparable managers: 1 buyer (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +568,131.

Managers listing GRDN in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Woodline Partners LP568,131$9.5m0.08%Newnew14 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

There is no earlier quarter on file to compare with.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

01122Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
GRDN by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20241$9.5m10
Q4 20241$8.4m01
Q1 20251$9.0m10
Q2 20251$22m10
Q3 20251$28m10
Q4 20251$32m1210
Q1 20262$55m148
Q2 20262$69m814

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

GRDN and PM →GRDN and KO →GRDN and COST →Choose a stock to compare with GRDN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own GRDN, latest filings →Back to the 13F Explorer →